Sort   by:  
 Page size 
ProteomicsComplex II assembly drives metabolic adaptation to OXPHOS dysfunction
During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be...
ORGANISM(S): Homo sapiens (Human) 
2025-06-06 | PXD064653 | Pride
Mitochondria Oxphos Sdh 
ProteomicsComplex II assembly drives metabolic adaptation to OXPHOS dysfunction
During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be...
ORGANISM(S): Homo sapiens (Human) 
2025-06-06 | PXD064649 | Pride
Mitochondria Tca cycle Oxphos Sdh 
ProteomicsComplex II assembly drives metabolic adaptation to OXPHOS dysfunction.
During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be...
ORGANISM(S): Homo sapiens (Human) 
2025-06-06 | PXD064675 | Pride
Mitochondria Tca cycle Oxphos Sdh 
ProteomicsComplex II assembly drives metabolic adaptation to OXPHOS dysfunction
During acute oxidative phosphorylation (OXPHOS) dysfunction, the reverse activity of succinate dehydrogenase (Complex II) maintains the redox state of the Coenzyme Q pool by utilizing either fumarate or oxygen as terminal electron acceptors. The tendency for one over another has been suggested to be...
ORGANISM(S): Homo sapiens (Human) 
2025-06-06 | PXD064658 | Pride
Mitochondria Tca cycle Oxphos Sdh 
UnknownHigh-content high-throughput imaging reveals distinct connections between mitochondrial morphology and functionality for OXPHOS complex I, III, and V inhibitors.
Not available
S-EPMC10247858 | biostudies-literature
UnknownRepurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Not available
S-EPMC5085139 | biostudies-literature
ProteomicsETFDH, CIII and COQ2 common interactome
Proteomic analysis of the immunocapture (IP) of COQ2, ETFDH and UQCRC2 in skeletal muscle extracts, searching for common interactors Coenzyme Q (Q) is a key lipid electron transporter, but several aspects of its biosynthesis and redox homeostasis remain undefined. Various flavoproteins reduce the Q;...
ORGANISM(S): Mus musculus (Mouse) 
2023-10-24 | PXD045351 | Pride
Etfdh  coenzyme q  oxphos-complex iii  skeletal muscle 
ProteomicsETFDH comigrates with CIII in BN-PAGE
Proteomic analysis of 13 bands from BN-PAGE immunostaining of mouse skeletal muscle mitochondrial proteins: Coenzyme Q (Q) is a key lipid electron transporter, but several aspects of its biosynthesis and redox homeostasis remain undefined. Various flavoproteins reduce the Q; however, in eukaryotes, ...
ORGANISM(S): Mus musculus (Mouse) 
2023-10-24 | PXD045352 | Pride
Coenzyme q  oxphos-complex iii  skeletal muscle  mitochondria 
UnknownPoor glycaemic control in type 2 diabetes compromises leukocyte oxygen consumption rate, OXPHOS complex content and neutrophil-endothelial interactions.
Not available
S-EPMC11893319 | biostudies-literature
UnknownDifferential proteomic profiling unveils new molecular mechanisms associated with mitochondrial complex III deficiency.
Not available
S-EPMC4259860 | biostudies-literature
Sort   by:  
 Page size